Balance Sheet for Evofem Biosciences Inc. (EVFM)

$ 3.30   0.13 (+4.10%) Volume: 4.06m 4:00 PM EDT 8-Jul-2020
After Hours:  $ 3.32   0.02 (+0.61%) Volume: 28.19k 7:59 PM EDT 8-Jul-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 15,571 1,330 1,211 11,478 37,749
Restrictable Cash 304 431 490 - -
Marketable Securities 8,233 - - - -
Accounts Receivable 686 250 267 - -
Loans Receivable - - - - -
Other Receivables 436 - - - -
Receivables 686 250 267 - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 972 199 278 1,030 1,977
Current Deferred Income Taxes - - - - -
Other Current Assets 655 268 108 - -
Total Current Assets 26,421 2,478 2,354 12,507 39,726
Land and Improvements - - - - -
Buildings and Improvement 340 340 340 - -
Machinery, Furniture and Equipment 826 857 850 254 280
Construction in Progress 77 - - - -
Fixed Assets, Other 160 - - - -
Fixed Assets, Total 1,403 1,197 1,190 254 280
Gross Fixed Assets 1,403 1,197 1,190 254 280
Accumulated Depreciation (849) (604) (342) (145) (93)
Net Fixed Assets 554 593 848 109 186
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 750 - 93 200 200
Total Non-Current Assets 1,874 1,532 1,598 309 386
Total Assets 28,295 4,010 3,952 12,817 40,112
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 5,958 8,694 8,999 105 4,017
Short Term Debt 197 - - 1,976 2,756
Notes Payable - 4,010 - - -
Accrued Expenses 2,784 11,513 12,074 398 2,326
Accrued Liabilities 2,784 11,513 12,074 398 2,326
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 3,720 3,112 82,274 (1,577) -
Total Current Liabilities 12,659 27,329 103,347 902 9,100
Long Term Debt N/A N/A N/A 5,964 7,205
Deferred Income Tax - 37 114 - -
Other Non-Current Liabilities - 37 (189,591) (5,964) -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - 37 280 - 7,205
Total Liabilities 12,659 27,366 103,627 902 16,305
Preferred Shareholder's Equity - - 189,871 - -
Common Shareholder's Equity 15,636 (23,356) (289,546) 11,915 23,807
Common Par 5 3 - 0 1
Additional Paid in Capital 528,810 409,787 17,731 137,765 136,638
Cumulative Translation Adjustments - - - - -
Retained Earnings (513,179) (433,146) (307,277) (125,850) (112,832)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 15,636 (23,356) (99,675) 17,879 31,012
Total Equity 15,636 (23,356) (99,675) 11,915 23,807
Total Liabilities & Shareholder's Equity 28,295 4,010 3,952 12,817 40,112
Cash Flow (80,033) (125,778) (109,322) (13,019) (43,157)
Working Capital 13,762 (24,851) (100,993) 11,605 30,626
Free Cash Flow (55,261) (56,507) (19,248) (16,255) (38,138)
Invested Capital 15,636 (23,356) (99,675) 11,915 31,012
Shares Outstanding - Common Class Only 48,138 25,867 2,308 2,305 2,292
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 48,138 25,867 2,308 2,305 2,292
Total Common Shares Outstanding 48,138 25,867 2,308 2,305 2,292
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 40,229 21,901 1,960 2,300 2,283
Diluted Weighted Shares Outstanding 40,229 21,901 1,960 2,300 2,283